gene-modified tumor cell vaccine therapy
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 1991 (NCT00002748)
Timeline
1990s
- Jan 1, 1991
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gene-modified tumor cell vaccine therapy
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00002637 | Phase 1/Phase 2 (Phase 2) | Jan 1, 1995 | Cornell University |
| NCT00002748 | Phase 1 | Dec 1, 1991 | National Cancer Institute (NCI), St. Jude Children's Hospital |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cornell University | Academic/Hospital | 1 | 1 | 1 | 1995 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 1991 |
| St. Jude Children's Hospital | Academic/Hospital | 1 | 1 | 1 | 1991 |
3 organizations
Page 1 / 1